BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1850695)

  • 21. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
    Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom-1 gene.
    Burk O; Klempnauer KH
    Biochim Biophys Acta; 1999 Sep; 1446(3):243-52. PubMed ID: 10524199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP-1) and stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription.
    White LA; Maute C; Brinckerhoff CE
    Connect Tissue Res; 1997; 36(4):321-35. PubMed ID: 9610890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.
    Gutman A; Wasylyk B
    EMBO J; 1990 Jul; 9(7):2241-6. PubMed ID: 2162765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of the ets gene family.
    Laudet V; Niel C; Duterque-Coquillaud M; Leprince D; Stehelin D
    Biochem Biophys Res Commun; 1993 Jan; 190(1):8-14. PubMed ID: 8422262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the cDNA sequences of two Xenopus ets-2 proto-oncogenes.
    Burdett LA; Qi S; Chen ZQ; Lautenberger JA; Papas TS
    Nucleic Acids Res; 1992 Jan; 20(2):371. PubMed ID: 1741266
    [No Abstract]   [Full Text] [Related]  

  • 28. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
    Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
    Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter.
    Majérus MA; Bibollet-Ruche F; Telliez JB; Wasylyk B; Bailleul B
    Nucleic Acids Res; 1992 Jun; 20(11):2699-703. PubMed ID: 1614856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression.
    Lemarchandel V; Ghysdael J; Mignotte V; Rahuel C; Roméo PH
    Mol Cell Biol; 1993 Jan; 13(1):668-76. PubMed ID: 8417360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism.
    Lim F; Kraut N; Framptom J; Graf T
    EMBO J; 1992 Feb; 11(2):643-52. PubMed ID: 1311254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
    Galang CK; Der CJ; Hauser CA
    Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a second promoter in the human c-ets-2 proto-oncogene.
    Bègue A; Crepieux P; Vu-Dac N; Hautefeuille A; Spruyt N; Laudet V; Stehelin D
    Gene Expr; 1997; 6(6):333-47. PubMed ID: 9495315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene.
    Wu H; Moulton K; Horvai A; Parik S; Glass CK
    Mol Cell Biol; 1994 Mar; 14(3):2129-39. PubMed ID: 8114743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
    Sistonen L; Hölttä E; Mäkelä TP; Keski-Oja J; Alitalo K
    EMBO J; 1989 Mar; 8(3):815-22. PubMed ID: 2498084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
    Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
    Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.